Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
 Contract - EconoTimes)
ATLANTA, Feb. 28, 2017 -- DLH Holdings Corp. (NASDAQ:DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to Federal agencies, today announced it has been awarded the Substance Abuse and Mental Health Services Administration (SAMHSA) multiple award, Indefinite Delivery Indefinite Quantity (IDIQ), performance-based contract. SAMHSA is an operating division within the U.S. Department of Health and Human Services (HHS) and is charged with reducing the impact of substance use disorders and mental illness on America’s communities.
As a prime contractor, DLH will provide SAMHSA officials with support services to help achieve administration goals within the areas of policy analysis, program management support, and statistical projects. "Winning this award means a lot to us. I am proud that we have been able to leverage our strengths in behavioral health, big data and health informatics to be in position to help SAMHSA with this vital area challenging our nation," said DLH President of Mission Services and Solutions Helene Fisher. “We look forward to working with them to deliver transformative services that will advance behavioral health within our communities.”
The company will be able to compete for task orders for up to a five-year period, further establishing the firm as a top provider of health technology-enabled business process outsourcing and program management solutions in support of large-scale federal health and human services initiatives.
About DLH
DLH (NASDAQ:DLHC) serves clients throughout the United States as a healthcare and human services provider to the Federal Government. The company’s core competencies include assessment and compliance monitoring, business process outsourcing, health information technology systems integration and management, readiness and medical logistics, and pharmacy solutions. DLH has more than 1,400 employees working throughout the country. For more information, visit the corporate website at www.dlhcorp.com.
CORPORATE COMMUNICATIONS Contact: Tiffany McCall Phone: 404–334–6000 Email: [email protected] INVESTOR RELATIONS Contact: Chris Witty Phone: 646–438–9385 Email: [email protected]
